A case report of leukocytapheresis for refractory leg ulcers complicated with rheumatoid arthritis

Therapeutic Apheresis and Dialysis

Volumn 10, Issue 5, 2006, Pages 419-424

  Itoh, Yoko ^a   Takeshita, Yasuyo ^a   Ozawa, Yoshinori ^a   Tohma, Shigeto ^a   Umemura, Satoshi ^b  

^a SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Leg ulcer; Leukocytapheresis; Rheumatoid arthritis

Indexed keywords

AUROTHIOMALATE; BUCILLAMINE; C REACTIVE PROTEIN; METHOTREXATE; PENICILLAMINE; PREDNISOLONE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADULT; AGED; ANAMNESIS; ARTHRALGIA; ARTICLE; CASE REPORT; CYTAPHERESIS; DOSE RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; LEG ULCER; LEUKOCYTE; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN ULCER; THERMOGRAPHY; ULCER HEALING;

AGED; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HUMANS; LEG ULCER; LEUKAPHERESIS; LEUKOCYTE COUNT; MIDDLE AGED; RHEUMATOID FACTOR; THERMOGRAPHY;

EID: 33750441157     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2006.00405.x     Document Type: Article

References (24)

1. Kondoh T, Hidaka Y, Kotoh H, Inoue N, Saito S. Evaluation of a Filtration Lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis. Artif Organs 1991;15:180-8.
2. Ueki Y, Nakamura H, Kanamoto Y et al. Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis. Ther Apher 2001;5:455-61.
3. Hidaka T, Suzuki K, Matsuki Y et al. Filtration Leukocytapheresis therapy in rheumatoid arthritis. A rondomized, double-blind, placebo-controlled trial. Arthritis Rheum 1999;42:431-7.
4. Kempe K, Tsuda H, Yang K, Yamaji K, Kanai Y, Hashimoto H. Filtration leukocytapheresis therapy in the treatment of rheumatoid arthritis patients resistant to or failed with methotrexate. Ther Apher Dial 2004;8:197-205.
5. Ueki Y, Yamasaki S, Kanamoto Y et al. Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis. Rheumatology 2000;39:165-71.
6. Hidaka T, Suzuki K. Efficacy of filtration leukocytapheresis on rheumatoid arthritis with vasculitis. Ther Apher 1997;1:212-14.
7. Yamaji K, Tsuda H, Hashimoto H. Current topics on cytapheresis technologies. Ther Apher 2001;5:287-92.
8. Hidaka T, Suzuki K, Kawakami M et al. Dynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. J Clin Apheresis 2001;16:74-81.
9. Hidaka T, Suzuki K. Leukocytapheresis for rheumatic diseade. Ther Apher Dial 2003;7:161-4.
10. Nagashima M, Yashino S, Tanaka H, Yoshida N, Kashiwagi N, Saniabadi AR. Granulocyte and monocyte apheresis suppresses symptoms of rheumatoid arthritis: a pilot study. Rheumatol Int 1998;18:113-18.
11. Sanmarti R, Marsal S, Valverde J et al. Adsorptive granulocyte/ monocyte apheresis for the treatment of refractory rheumatoid artheitis: an open pilot multicentre trial. Rheumatology 2005;44:1140-4.
12. Ohara M, Saniabadi AR, Kokuma S et al. Granulocytapheresis in the Treatment of Patients with Rheumatoid Arthritis. Artif Organs 1997;21:989-94.
13. Felson DT, Anderson JJ, Boers M et al. The American College of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
14. Mori S, Nagashima M, Yoshida K et al. Granulocyte adsorptive apheresis for leg ulcers complicated by rheumatoid arthritis: a report on three successfully treated cases. Int J Dermatol 2004;43:732-5.
15. Kaneko T. Granylocyte and monocyte adsorption apheresis for refractory skin disease. Jpn J Apheresis 2005;24:179-89.
16. Fujimoto E, Fujimoto N, Kuroda K, Tajima S. Leukocytapheresis treatment for pyoderma gangrenosum. Br J Dermatol 2004;151:1090-2.
17. Kanekura T, Maruyama I, Kanzaki T. Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum. J Am Acad Dermatol 2002;47:320-1.
18. Yamaji K, Yang K, Tsuda H, Hashimoto H. Fluctuations in the peripheral blood leukocyte and platelet counts in leukocytapheresis in healthy volunteers. Ther Apher 2002;6:402-12.
19. Hidaka T, Suzuki K, Matsuki YT et al. Filtration leukocytapheresis therapy in rheumatoid arthritis. Arthritis Rheum 1999;42:431-7.
20. Hidaka T, Suzuki K. The mechanism of the efficiency of leukocytapheresis on rheumatoid. Arthritis 1997;1:215-18.
21. Hidaka T, Suzuki K, Matsuki YT et al. Changes in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. Ther Apher 1999;3:178-85.
22. Yamasaki S, Ueki Y, Nakamura H et al. Effect of filtration leukocytapheresis therapy: modulation of white blood cell enzyme activities in patients with rheumatoid arthritis. Artif Organs 2002;26:378-84.
23. Andoh A, Ogawa A, Kitamura K et al. Suppression of interleukin-1 beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis. J Gastroenterol 2004;39:1150-7.
24. Okamoto R, Yajima T, Yamazaki M et al. Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med 2002;8:1011-17.